In the news earlier this month was a story about baby KJ, who made headlines because of a custom treatment he received for a ...

Intellia has leveraged its expertise in Crispr/Cas9 gene editing to advance a pipeline of in vivo and ex vivo therapies for diseases with high unmet medical needs. We believe Intellia's proprietary ...

Researchers at the Max Planck Institute for Evolutionary Anthropology have addressed a longstanding challenge in CRISPR ...

Doudna's insights on the future of CRISPR in medicine and agriculture, including the barriers that must be overcome to pave ...

In the assessment of 12-month price targets, analysts unveil insights for Intellia Therapeutics, presenting an average target ...

On May 12, 2025, the Court of Appeals for the Federal Circuit vacated-in-part and remanded a Patent Trial and Appeal Board (“PTAB”) decision in ...

Scientists at the McGovern Institute for Brain Research at MIT and the Broad Institute of MIT and Harvard have re-engineered ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

New studies show that astrocytes, long thought to be support cells in the brain, are crucial intermediaries for relaying messages to neurons.

The birth took place at Sher-e-Kashmir University of Agricultural Sciences and Technology (SKUAST-Kashmir). Officials say it ...

Srinagar- Researchers at the Sher-e-Kashmir University of Agricultural Sciences and Technology (SKUAST) here have produced ...

In 2012, scientists Jennifer Doudna and Emmanuelle Charpentier replicated this mechanism found in microbes to develop a ...